Atlas Trials

Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT00025285 · COMPLETED

Trial details

NCT number
NCT00025285
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2001-11-01
Primary completion
2004-09-29
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.